A patient with psoriasis is started on a TNF-α inhibitor. What is the major risk of this therapy?
Show answer and explanation
Correct answer: Latent tuberculosis reactivation
TNF-α inhibitors suppress immune function, increasing risk of latent TB reactivation. Screening for TB is required before treatment.
Practice all 20 Musculoskeletal and Skin: Osteoporosis, Psoriasis questions
Keep practicing
More Musculoskeletal and Skin: Osteoporosis, Psoriasis questions
- A 65-year-old woman with osteoporosis begins teriparatide therapy. What is its mechanism?
- A pediatric patient with guttate psoriasis presents after a recent streptococcal infection. What is the typical distribution of lesions?
- A patient presents with low-trauma fractures. Which lifestyle factor contributes most strongly to osteoporosis?
- Which finding is characteristic of psoriatic arthritis rather than osteoarthritis?
- A patient with osteoporosis begins denosumab therapy. Which pathway is targeted?
- Which of the following nail findings is MOST specific for psoriasis?